Liver Cancer News

Blue Faery: The Adrienne Wilson Liver Cancer Association

AA

A A

Liver Cancer News

Print Friendly, PDF & Email

Click on the title to read the rest of the Liver Cancer News story.

December 2021

Study Uses Metabolomics To Discriminate Drug-Induced Liver Injury Phenotypes

Puerto Ricans Continue To Be At Higher Risk Of Developing Hepatocellular Cancer, Study Indicates

FDA Grants Fast Track Designation To Liocyx-M004 For HBV-Related Hepatocellular Carcinoma

Are Immune Checkpoint Inhibitors Better Than Standard Care For Unresectable HCC?

With A ‘Biological Computer,’ Scientists Look To Target Cancer While Sparing Healthy Cells

Part 2: Factors For Considering Transplant Or Immunotherapy In HCC

Last Liver Cancer Patient In Phase II Trial Of Namodenoson Found Cleared Of All Lesions

HCC Prevention Should Be Targeted To Patients With Moderate Fibrosis

Precisely Targeting Liver Cancer With Logic-Gated Gene Therapy

Who Is At Risk For Liver Cancer After Hepatitis C Treatment?

Rates Of HCC Rising In Black Patients Without Cirrhosis

Part 1: Using Scans And Biopsy To Diagnose HCC

Research In Primary Liver Cancer Calls For Novel Strategies Targeting Dynamic Landscape Of Heterogeneous Tumors

This Is Your Liver On Hep C

CRISPR/Cas9 Gene-Editing Boosts Effectiveness Of Ultrasound Cancer Therapy

Destroying Liver Tumor With Sound Waves: Baptist Health First In S. Florida To Use Non-Invasive Tech In Clinical Trial

Helioliver™, An Innovative Liquid Biopsy Test For The Early Detection Of Liver Cancer, Is Now Commercially Available

Mount Sinai Researchers Awarded $3.15 Million To Advance A Multidisciplinary Drug Development Platform For Hepatocellular Carcinoma

November 2021

Scores Based on Simple Test Parameters Predict Outcomes for Liver Cancer Patients Receiving Immunotherapy

Exelixis Announces Detailed Results from Phase 3 COSMIC-312 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Patients with Previously Untreated Advanced Liver Cancer

Eureka Therapeutics Announces Initiation of Phase I/II ARYA-2 Clinical Trial of ET140203 ARTEMIS® T Cells to Treat Pediatric Liver Cancer

Combinatorial Serum Protein Panel ‘Promising’ in Early HCC Detection

Promising Treatment for Advanced Hepatocellular Carcinoma Enters Clinical Trials

FOLFOX Chemotherapy is Superior to TACE in Liver Cancer

High Iron Levels in Blood Linked to Increased Risk of Liver Cancer in NAFLD

HCC Reoccurs in 1 of 7 Following Liver Transplantation

Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC)

Updates to Adjuvant and Neoadjuvant Therapy in Early HCC

Finding the Optimal Therapeutic Sequence for Advanced Hepatocellular Carcinoma

A Target for Potential Cancer Drugs May, In Fact, Worsen Disease

FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer

Goals for TACE and Immunotherapy Trial in Intermediate-Stage HCC

Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection

Noninvasive Bridging Therapy Underutilized Versus More Invasive Options in Transplant-Eligible Hepatocellular Carcinoma

Kerala’s local herb ‘Manathakkali’ approved for liver cancer, research gets US FDA nod

Novel Blood-Based Panel Highly Effective for Early-Stage HCC

Thermal ablation combined with transarterial chemoembolization for hepatocellular carcinoma: What is the right treatment sequence?

October 2021

Weight Loss Medications May Reduce Risk For Cirrhosis And Hepatocellular Carcinoma

Early-Stage Immunotherapy Use In HCC Produces High Response Rate

Genetron Health’s Liver Cancer Screening Results And Technology Findings Included In The Chinese Journal of Hepatology

New System Created For Targeted Delivery Of Anti-Cancer Drugs

Liver Cancer Screening: Detecting A ‘Silent’ Condition

Liver Cancer Awareness Q&A With Ariel Jaffe, MD

Dr. Heimbach On The Need For Multidisciplinary Care In HCC

October Is Liver Cancer Awareness Month

External-beam Radiation Therapy Underused For People With Liver Cancer Awaiting Transplant

Arterial Chemo Tops Chemoembolization For Large Liver Tumors

Sure Signs You May Have Liver Damage, Say Experts

Abou-Alfa Gives Expert Insights For Liver Cancer Awareness Month

UQ Start-Up Secures $1.3 Million Seed Investment To Develop New Treatment For Liver Disease

MiRNA Expression in Cirrhosis and Liver Cancer

Kintor Pharma Announces China NMPA Approves Clinical Trial Of ALK-1 And Nivolumab Combination Therapy For The First-line Treatment of Advanced Hepatocellular Carcinoma

Sirtex Medical And China Grand Pharmaceutical Announce Successful First Administration of SIR-Spheres® Y-90 Resin Microspheres In China

New Artificial Intelligence Offers Hope For Liver Cancer Patients With Less Than 13 Percent Chance of Survival

Vogel Discusses Real-World Survival Data Of Immunotherapy In HCC

Hope On The Horizon For Liver Cancer Patients As This Company’s Namodenoson Drug Starts Pivotal Phase III Global Trial

Tremelimumab/Durvalumab Combo Safe And Efficacious For Unresectable Hepatocellular Carcinoma

Roundtable Discussion: Abou-Alfa And Participants Cover Biopsies And Treatment In HCC

Ronawk Using Stem Cell Tech Developed At Olathe Lab To Advance Liver Cancer Research In Turkey

Surface Oncology Announces New Randomized Phase 2 Clinical Study Evaluating SRF388 In Patients With First-Line Hepatocellular Carcinoma In Clinical Collaboration With Roche

Nivolumab Continues To Elicit Durable Responses In Advanced HCC

Optimizing Precision Medicine In HCC

Roundtable Discussion: Finn Explores Treatment For Unresectable HCC

Therapeutic Approaches For The Treatment Of Hepatocellular Carcinoma

 

For past liver cancer news, please visit our Liver Cancer News Archives.